You are viewing the site in preview mode

Skip to main content

Advertisement

Table 5 Drug-administration by regimen, n = 726

From: Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study

Drug administration 3RHa daily 3RPHb weekly Otherc Total
Number of individuals 399 (100) 306 (100) 21 (100) 726 (100)
Self-administered 220 (55) 20 (7) 14 (67) 254 (35)
Direct observed treatment
 Whole period 132 (33) 269 (88) 3 (14) 404 (56)
 Part of period 41 (10) 11 (4) 3 (14) 55 (8)
 Missing information 6 (2) 6 (2) 1 (5) 13 (2)
  1. Data are presented as n (%)
  2. arifampicin (R) and isoniazid (H) daily for three months
  3. brifapentine (RP) and isoniazid (H) in 12 weekly doses
  4. cIrifampicin (R) monotherapy daily for four months (n = 5), Isoniazid (H) monotherapy for six months (n = 13) or combination therapy for TB disease (n = 2) and missing information (n = 1)
  5. dOther included: hospital outpatient clinic, assisted living facilities, refugee centres, work-places or with general practitioners.